• Chronic Myeloid Leukemia: A Review

  • 2025/03/17
  • 再生時間: 17 分
  • ポッドキャスト

Chronic Myeloid Leukemia: A Review

  • サマリー

  • Chronic myeloid leukemia is a myeloproliferative neoplasm that affects approximately 5 million people worldwide. Tyrosine kinase inhibitors, such as imatinib, have substantially improved survival in patients with chronic myeloid leukemia. In this podcast, author Elias J. Jabbour, MD, of the University of Texas MD Anderson Cancer Center, discusses diagnosis and treatment of chronic myeloid leukemia with JAMA Deputy Editor Mary McDermott, MD.

    Related Content:

    • Chronic Myeloid Leukemia
    続きを読む 一部表示

あらすじ・解説

Chronic myeloid leukemia is a myeloproliferative neoplasm that affects approximately 5 million people worldwide. Tyrosine kinase inhibitors, such as imatinib, have substantially improved survival in patients with chronic myeloid leukemia. In this podcast, author Elias J. Jabbour, MD, of the University of Texas MD Anderson Cancer Center, discusses diagnosis and treatment of chronic myeloid leukemia with JAMA Deputy Editor Mary McDermott, MD.

Related Content:

  • Chronic Myeloid Leukemia

Chronic Myeloid Leukemia: A Reviewに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。